Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MME | P08473 | 2/20 | 0.46 |
| ▸ | ANPEP | P15144 | 2/20 | 0.46 |
| ▸ | MMP1 | P03956 | 1/20 | 0.45 |
| ▸ | MMP3 | P08254 | 1/20 | 0.45 |
| ▸ | ERAP2 | Q6P179 | 3/20 | 0.43 |
| ▸ | LNPEP | Q9UIQ6 | 3/20 | 0.43 |
| ▸ | ERAP1 | Q9NZ08 | 1/20 | 0.43 |
| ▸ | MMP2 | P08253 | 1/20 | 0.43 |
| ▸ | MMP9 | P14780 | 1/20 | 0.43 |
| ▸ | MMP8 | P22894 | 1/20 | 0.43 |
| ▸ | MMP14 | P50281 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20526402 | 0.86 | MME (0.55) | MMEANPEPMMP2MMP9MMP8 | |
| SCHEMBL12596616 | 0.85 | ECE1 (0.54) | MMEMMP1MMP3MMP2MMP9 | |
| SCHEMBL1763989 | 0.85 | ECE1 (0.54) | MMEMMP1MMP3MMP2MMP9 | |
| SCHEMBL1763939 | 0.85 | MME (0.55) | MMEANPEPMMP2MMP9MMP8 | |
| SCHEMBL12596609 | 0.85 | MME (0.55) | MMEANPEPMMP2MMP9MMP8 | |
| SCHEMBL1764587 | 0.84 | MME (0.52) | MMEANPEPMMP2MMP9MMP8 | |
| SCHEMBL12596611 | 0.84 | MME (0.52) | MMEANPEPMMP2MMP9MMP8 | |
| SCHEMBL1764171 | 0.84 | MME (0.55) | MMEANPEPMMP2MMP9MMP8 | |
| SCHEMBL12596605 | 0.84 | MME (0.55) | MMEANPEPMMP2MMP9MMP8 | |
| SCHEMBL1764379 | 0.84 | MME (0.65) | MMEANPEP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3383403-A1 | AMINOPHOSPHINIC DERIVATIVES FOR PREVENTING AND TREATING EYE PAIN | Pharmaleads (FR) | 2018-10-10 | — | — | EP | disclosed |